World Health Organization Sounds Concern Over Severe Lack of Obesity Jabs
Fewer than one in 10 individuals eligible to benefit from weight-loss injections such as Wegovy can access them, caution the global health agency as it releases its first guidance on the medications.
Given in excess of 1,000,000,000 people worldwide currently living with obesity, it is urging more widespread and fairer access to these injectable treatments.
According to estimates, more than two billion are projected to be obese by 2030 unless action is taken.
"The new guidance affirms that excess weight is a chronic disease that can be managed with comprehensive and continuous support," said WHO director-general Tedros Adhanom Ghebreyesus.
Significant expense, constrained manufacturing, and supply-chain constraints are key obstacles to broad access to the jabs that can aid individuals in losing considerable body mass, says the agency.
Skinny Jab Shortage
Even in the current most optimistic outlook, the manufacturing of GLP-1 therapies could only cover approximately 100 million people – under 10% of the global need, according to the health organization.
The advice urges nations and manufacturers to expand availability, via approaches like voluntary licensing.
A patent on the active ingredient – the primary ingredient of a leading brand – is set to lapse in several nations in 2026.
The Way Obesity Jabs Work
The injections mimick a body's own hormone to slow digestion, suppress the appetite and enhance feelings of fullness so individuals consume fewer calories.
Individuals usually begin shedding pounds after several weeks of starting on the weekly injections.
Research indicates users may regain a significant portion a year later of discontinuing the drug, as their normal appetite come back.
To be above a healthy weight raises your risk for developing health problems, like diabetes, cardiovascular issues, stroke, and some cancers.
Excess weight concerns people in all nations and was responsible for 3.7 million fatalities worldwide in 2024, as per the health agency.